The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force
Abstract
PURPOSE: To assess the effectiveness of different colorectal cancer screening tests for adults at average risk. DATA SOURCES: Recent systematic reviews; Guide to Clinical Preventive Services, 2nd edition; and focused searches of MEDLINE from 1966 through September 2001. The authors also conducted hand searches, reviewed bibliographies, and consulted context experts to ensure completeness. STUDY SELECTION: When available, the most recent high-quality systematic review was used to identify relevant articles. This review was then supplemented with a MEDLINE search for more recent articles. DATA EXTRACTION: One reviewer abstracted information from the final set of studies into evidence tables, and a second reviewer checked the tables for accuracy. Discrepancies were resolved by consensus. DATA SYNTHESIS: For average-risk adults older than 50 years of age, evidence from multiple well-conducted randomized trials supported the effectiveness of fecal occult blood testing in reducing colorectal cancer incidence and mortality rates compared with no screening. Data from well-conducted case-control studies supported the effectiveness of sigmoidoscopy and possibly colonoscopy in reducing colon cancer incidence and mortality rates. A nonrandomized, controlled trial examining colorectal cancer mortality rates and randomized trials examining diagnostic yield supported the use of fecal occult blood testing plus sigmoidoscopy. The effectiveness of barium enema is unclear. Data are insufficient to support a definitive determination of the most effective screening strategy. CONCLUSIONS: Colorectal cancer screening reduces death from colorectal cancer and can decrease the incidence of disease through removal of adenomatous polyps. Several available screening options seem to be effective, but the single best screening approach cannot be determined because data are insufficient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Strong direct and inferential evidence indicates that screening for colorectal cancer and adenomatous polyps reduces both mortality from and incidence of this disease.130,131”
Citations
Cites
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
Winawer, S. J., Zauber, A. G., Ho, M. N., O’Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292701 · Cited by 4,585
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,220
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
Hardcastle, J. D., Chamberlain, J., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., James, P., & Mangham, C. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03386-7 · Cited by 2,784
Randomised study of screening for colorectal cancer with faecal-occult-blood test
Kronborg, O., Fenger, C., Olsen, J., Jørgensen, O. D., & Søndergaard, O. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03430-7 · Cited by 2,495
Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer
Lieberman, D. A., Weiss, D. G., Bond, J. H., Ahnen, D. J., Garewal, H. S., Harford, W. V., Provenzale, D., SONTAG, S., Schnell, T., Durbin, T. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430301 · Cited by 1,810
Current methods of the U.S. Preventive Services Task Force
Harris, R., Helfand, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D., Teutsch, S. M., & Atkins, D. C. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00261-6 · Cited by 1,720
Self-citationA Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal Cancer
Selby, J. V., FRIEDMAN, G. D., Quesenberry, C. P., & Weiss, N. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261001 · Cited by 1,700
Colorectal cancer screening: Clinical guidelines and rationale
Winawer, S. J., Fletcher, R. H., Miller, L. C., Godlee, F., Stolar, M. H., Mulrow, C. D., Woolf, S. H., Glick, S. N., Tg, G., Bond, J. H., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.agast970594 · Cited by 1,605
Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies
Rex, D. K., Cutler, C., Lemmel, G. T., Rahmani, E. Y., Clark, D., Helper, D. J., Lehman, G. A., & Mark, D. G. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70214-2 · Cited by 1,552
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
Mandel, J. S., Church, T. R., Bond, J. H., Ederer, F., Geisser, M. S., Mongin, S. J., Snover, D. C., & Schuman, L. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432203 · Cited by 1,421
Flagged first, then by citations
Research works printed but not linked: 9
- Yamamoto M, 2000, Hepatogastroenterology, 47, 396
- 10.1001/archinte.1991.00400110044009 · DOI
- Berry DP, 1997, Br J Surg, 84, 1274
- Foliente RL, 1996, Am J Gastroenterol, 91, 705
- Lo AY, 1994, J Am Coll Surg, 179, 333
- DiPrima RE, 1988, Am J Gastroenterol, 83, 123
- Nivatvongs S, 1988, Am Surg, 54, 61
- Brynitz S, 1986, Ann Chir Gynaecol, 75, 142
- Rex DK, 2000, Am J Gastroenterol, 95, 868
Cited by
Sorted by citations
Eyre, H., Kahn, R., Robertson, R. M., the ACS/ADA/AHA Collaborative Writing Committee, ACS/ADA/AHA Collaborative Writing Committee Members, Clark, N. G., Doyle, C., Hong, Y., Gansler, T., Glynn, T., et al. (2004) · Circulation · doi:10.1161/01.cir.0000133321.00456.00 · Cited by 542
Prevalence of major risk factors and use of screening tests for cancer in the United States
Fedewa, S. A., Sauer, A. G., Siegel, R. L., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0134 · Cited by 77
Guillaume, E., Dejardin, O., Bouvier, V., De Mil, R., Berchi, C., Pornet, C., Christophe, V., Notari, A., Delattre Massy, H., De Seze, C., et al. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.08.012 · Cited by 41
Metadata
- Authors
- Pignone, M., Rich, M., Teutsch, S. M., Berg, A. O., & Lohr, K. N.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2002-07-16
- Volume
- 137
- Issue
- 2
- Pages
- 132-141
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2072878220
- Cited by
- 741
- References
- 64
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 8 · 2018: 10 · 2017: 13 · 2016: 15 · 2015: 28 · 2014: 36 · 2013: 24 · 2012: 33
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (290-97-0011)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- colorectal cancer screening, average-risk population, fecal occult blood test, sigmoidoscopy, colonoscopy, barium enema, colorectal cancer mortality, adenomatous polyps, colorectal cancer incidence, screening effectiveness
- MeSH terms
- Age Factors, Colonoscopy, Enema, Female, Humans, Male, Mass Screening, Middle Aged, Occult Blood, Physical Examination, Rectum, Sigmoidoscopy, Time Factors, Colorectal Neoplasms, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
